These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 810490)

  • 1. Selective breeding to establish a standard mouse for pertussis vaccine bioassay. II. Bioresponses of mice susceptible and resistant to sensitization by pertussis vaccine HSF.
    Manclark CR; Hansen CT; Treadwell PE; Pittman M
    J Biol Stand; 1975; 3(4):353-63. PubMed ID: 810490
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved protocols for histamine sensitization testing of acellular pertussis vaccines.
    Oh H; Joung J; Kim BG; Nam KT; Hong SH; Song HC; Lee HL; Ahn BY
    Vaccine; 2012 Nov; 30(50):7246-52. PubMed ID: 23084771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SENSITIZING PROPERTIES OF B. PERTUSSIS IN THE MOUSE AND RAT.
    GOEZSY B; KATO L
    Rev Can Biol; 1964 Sep; 23():427-37. PubMed ID: 14237174
    [No Abstract]   [Full Text] [Related]  

  • 4. Acetone-treated pertussis vaccine--a potent and safer new pertussis vaccine.
    Saran G
    J Biol Stand; 1985 Oct; 13(4):315-20. PubMed ID: 4055808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [SIGNIFICANCE AND MECHANISM OF SENSITIZATION AFTER PERTUSSIS VACCINATION].
    PEKAREK J
    Cesk Epidemiol Mikrobiol Imunol; 1964 Jan; 13():20-7. PubMed ID: 14109642
    [No Abstract]   [Full Text] [Related]  

  • 6. [The safety and protective properties of a new cell-free pertussis vaccine in animal trials].
    Bazhanova IG; Remova TN; Ozeretskovskaia MN; Shmeleva EI; Mertsalova NU; Sukhinova EE; Chuprinina RP; Bulk VF; Semina IE; Koval'skaia SIa
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (1):40-5. PubMed ID: 8184612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the stability of pertussis vaccine OCO-3 standard].
    Chuprinina RP; Alekseeva IA
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (5):68-71. PubMed ID: 15554317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. INVESTIGATIONS INTO THE MECHANISM OF PERTUSSIS VACCINE INDUCED HYPERSENSITIVITY. I. EFFECT OF HEMOPHILUS PERTUSSIS VACCINE ON CAPILLARY ENDOTHELIUM IN RATS.
    LAWLER R; CLAIRMONT JP; KATO L; GOEZSY B
    Int Arch Allergy Appl Immunol; 1965; 26():373-6. PubMed ID: 14328073
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action of Haemophilus pertussis vaccine on resistance to anaphylaxis, histamine allergy, serotonin, acetylcholine and infection, in the murine species and the human genus. Experiences in 30 allergic children with pertussis-tetanus-diphtheria triple vaccine].
    MATHOV E
    Sem Med; 1960 Sep; 117():1085-99. PubMed ID: 13768138
    [No Abstract]   [Full Text] [Related]  

  • 10. Endotoxin-induced hypersensitivity to histamine in mice. I. Contrasting effects of bacterial lipopolysaccharides and the classical histamine-sensitizing factor of Bordetella pertussis.
    Pieroni RE; Broderick EJ; Levine L
    J Bacteriol; 1966 Jun; 91(6):2169-74. PubMed ID: 5943934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LOCAL AND SYSTEMIC ANAPHYLAXIS IN THE PERTUSSIS-INOCULATED MOUSE.
    KIND LS; RICHARDS WW
    Nature; 1964 Apr; 202():309-10. PubMed ID: 14167807
    [No Abstract]   [Full Text] [Related]  

  • 12. Towards replacement of the acellular pertussis vaccine safety test: Comparison of in vitro cytotoxic activity and in vivo activity in mice.
    Wagner LD; Corvette LJ; Ngundi MM; Burns DL
    Vaccine; 2017 Dec; 35(51):7160-7165. PubMed ID: 29122386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplacental and transcolostral immunity to pertussis in a mouse model using acellular pertussis vaccine.
    Oda M; Izumiya K; Sato Y; Hirayama M
    J Infect Dis; 1983 Jul; 148(1):138-45. PubMed ID: 6309992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis.
    Vandebriel RJ; Gremmer ER; Vermeulen JP; Hellwig SM; Dormans JA; Roholl PJ; Mooi FR
    Vaccine; 2007 Mar; 25(12):2346-60. PubMed ID: 17224216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An aerosol challenge model of Bordetella pertussis infection as a potential bioassay for acellular pertussis vaccines.
    Xing DK; Das RG; Williams L; Canthaboo C; Tremmil J; Corbel MJ
    Vaccine; 1999 Feb; 17(6):565-76. PubMed ID: 10075163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whooping cough and pertussis vaccine: a comparison of risks and benefits in Britain during the period 1968-83.
    Stewart GT
    Dev Biol Stand; 1985; 61():395-405. PubMed ID: 3835080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and preliminary immunobiological characterization of a novel, non-reverting, intranasal live attenuated whooping cough vaccine candidate.
    Cornford-Nairns R; Daggard G; Mukkur T
    J Microbiol Biotechnol; 2012 Jun; 22(6):856-65. PubMed ID: 22573165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
    Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
    BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgE levels of infants with complications after pertussis vaccination.
    Osváth P; Csorba S; Endre L; Szabados B; Péter F
    Allergol Immunopathol (Madr); 1979; 7(2):111-4. PubMed ID: 463714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.